Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : 524742 | NSE Symbol : CAPLIPOINT | ISIN : INE475E01026 | Industry : Pharmaceuticals - Indian - Formulations |

(23-Apr-25 12:59) Caplin Steriles receives USFDA approval for Phytonadione Injectable Emulsion
(23-Apr-25 11:29) Caplin Point Lab arm receives final approval for Phytonadione Injectable Emulsion
(26-Feb-25 19:15) Caplin Steriles receives USFDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution
(26-Feb-25 14:17) Caplin Point Lab’s subsidiary gets USFDA approval for new eye drop solution
(07-Feb-25 17:34) Caplin Point Laboratories consolidated net profit rises 18.57% in the December 2024 quarter
(05-Feb-25 20:06) Caplin Steriles receives USFDA approval for Procainamide Hydrochloride Injection
(01-Feb-25 10:02) Caplin Point Laboratories to hold board meeting
(17-Jan-25 15:19) Caplin Point Laboratories receives USFDA approval for Levetiracetam in Sodium Chloride Injection
(17-Jan-25 12:57) Caplin Point Lab arm receives USFDA nod for seizures treatment injection
(07-Jan-25 14:45) Caplin Point gains after receiving EIR report from USFDA for Tamil Nadu facility

1 2 3 4 5 6 7 8 9 10

Caplin Point Laboratories Ltd